SciELO - Scientific Electronic Library Online

 
vol.64 número3COVID-19 y sobreinfección bacteriana: perfil clínico, microbiológico y determinantes de mortalidad en un centro de referencia en Quito, Ecuador.Transición epitelio - mesenquima y cáncer. índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Investigación Clínica

versión impresa ISSN 0535-5133versión On-line ISSN 2477-9393

Resumen

BICER, Senol et al. Effect of anakinra, tocilizumab, and the combination thereof on bladder ischemia- reperfusion damage in albino Wistar-type rats. Invest. clín [online]. 2023, vol.64, n.3, pp.368-378.  Epub 20-Sep-2023. ISSN 0535-5133.  https://doi.org/10.54817/ic.v64n3a09.

Several studies have reported that oxidative stress, and proinflammatory cytokines such as tumor necrosis factor-alpha (TNF-α), interleukin-one beta (IL-1β), and interleukin-six (IL-6) are the main factors underlying bladder ischemia-reperfusion (I/R) damage. Anakinra and tocilizumab are known to be antioxidants and proinflammatory cytokine inhibitors. Our study aims to investigate if anakinra, tocilizumab, and the combination (ATC) thereof have a protective effect against oxidative and inflammatory bladder damage induced through the I/R procedure in rats, and evaluate by comparing these compounds. Male rats were divided into five groups: bladder sham-operation applied group (SG); bladder only I/R applied group (IRG); anakinra+bladder I/R applied group (AIR); tocilizumab+bladder I/R applied group (TIR); and ATC+bladder I/R applied group (ATIR). An atraumatic clamp was placed on the abdominal aorta of animals in all groups (except SG), and one hour of ischemia followed by two hours of reperfusion was performed. Our biochemical findings showed that anakinra and tocilizumab significantly inhibited the increase of oxidant malondialdehyde (MDA) and the decrease of antioxidants such as total glutathione (tGSH), superoxide dismutase (SOD), and catalase (CAT) in bladder tissue by I/R, both at the same levels. Furthermore, anakinra and tocilizumab significantly suppressed the I/R-associated increase of TNF-α, IL-1β, and IL-6 in bladder tissue. ATC was the one that best prevented the I/R-related increase in MDA, TNF-α, IL-1β, and IL-6 and the decrease in tGSH, SOD, and CAT in the bladder tissue. ATC was more beneficial than anakinra or tocilizumab alone in treating bladder I/R damage.

Palabras clave : anakinra; anakinra and tocilizumab combination; bladder; ischemia-reperfusion damage; rats; tocilizumab.

        · resumen en Español     · texto en Inglés     · Inglés ( pdf )